Hone your POCUS interpretation and clinical reasoning by working through the interactive cases below.

 

Case #5: A sticky situation

This is the case of a 32 male with known active injection drug use,  and a history of MRSA tricuspid infective endocarditis 2 years prior.  He presented with several days of rapidly progressive malaise, and was found to be weakly moaning, tachycardic (HR 110s), hypotensive (SBP 80s), and mottled, with capillary refill >5s, though not in acute respiratory distress.

The patient was initially treated as “Sepsis NYD” with vancomycin and ceftriaxone, and volume expanded with 2Lof crystalloid prior to consultation.

POCUS was deployed for evaluation of shock NYD.

A consulting service became involved and administered another 2L of crystalloid. The patient’s status was relatively unchanged with this with no BP response, so norephinephrine was commenced. He was treated as primary vasodilatory shock secondary to sepsis from infective endocarditis and stabilized over the next 48 hours. Unfortunately, the patient left AMA prior to completing therapy.

To go back to the previous question, it seems that this patient did not in fact have any adverse response to additional volume administration (he was volume tolerant). However, given the R heart findings and suspicion of primary vasodilatory/septic shock, it would be very reasonable to have gone straight to vasopressors in this case.